Development of stealth liposome coencapsulating doxorubicin and fluoxetine
10.3109/08982104.2010.545070
Saved in:
Main Authors: | Ong, J.C.-L., Sun, F., Chan, E. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/108333 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes
by: Wang, J.-C., et al.
Published: (2014) -
In vitro cytotoxicity of stealth liposomes co-encapsulating doxorubicin and verapamil on doxorubicin-resistant tumor cells
by: Wang, J., et al.
Published: (2012) -
Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats
by: Wang, J.-C., et al.
Published: (2011) -
DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
by: SHAIKH MOHAMMED ISHAQUE
Published: (2012) -
Liposomal doxorubicin-associated acute hypersensitivity despite appropriate preventive measures
by: Chan, A., et al.
Published: (2014)